• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,708.52 -442.93
( -0.57%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Torrent Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
500420
INE685A01028
249.7348678
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TORNTPHARM
72.92
161323.4
EPS(TTM)
Face Value()
Div & Yield %
65.37
5
0.8
 

Basilic Fly Studio consolidated net profit declines 18.56% in the March 2026 quarter
May 30,2026
Net profit of Basilic Fly Studio declined 18.56% to Rs 13.60 crore in the quarter ended March 2026 as against Rs 16.70 crore during the previous quarter ended March 2025. Sales declined 15.12% to Rs 113.40 crore in the quarter ended March 2026 as against Rs 133.60 crore during the previous quarter ended March 2025.

For the full year,net profit rose 33.70% to Rs 48.80 crore in the year ended March 2026 as against Rs 36.50 crore during the previous year ended March 2025. Sales rose 34.10% to Rs 407.80 crore in the year ended March 2026 as against Rs 304.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales113.40133.60 -15 407.80304.10 34
OPM %21.0824.40 -20.8923.51 -
PBDT26.2030.50 -14 85.7067.30 27
PBT20.9027.00 -23 69.4055.10 26
NP13.6016.70 -19 48.8036.50 34